The upregulation of OLFM4 expression in the CR group suggests that environmental conditions at the tumor site, including bacterial infections other than Hp and the associated inflammation, may contribute to the response to eradication therapy. The gene discussed is OLFM4; the disease is bacterial infectious disease.